DOVER, DE (October 14, 2022) – The Delaware Division of Public Health (DPH) reports that the 7-day average of new positive COVID-19 cases has decreased for the third consecutive month. Deaths remain low, and hospitalization rates are holding steady. According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, which factors in data on hospitalizations and cases in each county to determine recommended community prevention strategies, COVID-19 community levels in Kent County are now high, Sussex County remains at medium, while levels in New Castle County continue to be listed as low as of October 13.    

 

This week, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to Pfizer for the bivalent booster for ages 5-11 and to Moderna for their bivalent booster for those ages 6-17 who have received their primary series of vaccination at least two months before (a minimum of two doses of Pfizer, Moderna or Novavax). The CDC Director also signed off on the expanded authorization.  Bivalent boosters were previously authorized on Aug. 31 for those ages 12+ for Pfizer, and for Moderna, ages 18+.  Moderna’s bivalent booster for ages 5-11 will utilize the same product as the adult booster, just at a lesser dose. Pfizer’s bivalent booster for youth will come in a separate vial as it requires dilution, while the adult formula does not, for more information, visit de.gov/boosters. 

 

The updated boosters target two strains of COVID-19: the original strain of the virus, and two of the Omicron variants (BA.4 and BA.5), currently, the most widespread variants in the world. To reduce confusion among the public and vaccine providers, and because they do not offer the increased levels of protection provided by the bivalent boosters, the original (monovalent) booster formula is no longer authorized for use in those 5 and older. Medical providers may no longer administer them. Individuals who have recently had COVID-19 are strongly encouraged to get a bivalent booster to optimize their protection, even if they received a monovalent booster before. Those who recently had COVID-19 should also get the new booster but should consider waiting three months after they have recovered from the virus.  

 

DPH strongly encourages everyone to get their bivalent booster as soon as they are eligible, and well in advance of any possible surge in the late fall or winter.   A recent Commonwealth Fund study found that if 80% of eligible individuals 5 and older receive their booster dose by the end of 2022, it would prevent about 90,000 deaths and more than 936,000 hospitalizations, while also preventing $56 billion in medical costs in the next six months. However, if the current pace of vaccinations remains unchanged nationwide through March 2023, a potential winter surge in the United States could result in as many as 16,000 hospitalizations and 1,200 deaths per day, the study found.  

 

Individuals may also get a booster at the same time as they get their annual flu vaccine, either in the same arm at least one inch apart, or in different arms. The Centers for Disease Control and Prevention encourages everyone 6 months older to get their flu vaccine by Halloween amid concerns of a potentially severe flu season. This week, DPH confirmed that flu is statewide and has already recorded the state’s first pediatric case of the season as well. Flu vaccines and bivalent boosters are available at DPH clinics, many pharmacies, Federally Qualified Health Centers and some community events. You can find a list of locations for COVID vaccines at de.gov/getmyvaccine. or at vaccines.gov. Locations for flu vaccines can be found on the flu finder on the flu.delaware.gov webpage. More details on the bivalent booster can be found at de.gov/boosters.  

 

The webpage also has a link to a flier for the public which highlights some similarities between the labels of bivalent boosters and some primary series vaccines. Those getting a booster are encouraged to print and take a copy of the flier with them, or pull it up on their phone’s web browser, and ask the vaccine provider to show them the vial that your bivalent booster is being drawn from so they can confirm it is the correct one. It is an important step in being an educated health consumer and advocate for your personal health.  

 

The below data is as reported on Delaware’s My Health Community data portal on Thursday, Oct. 13, 2022.  

 

COVID-19 Cases and Hospitalizations:  

• Total positive cases since March 11, 2020: 310,819*
• 7-day daily average of new positive cases: 146.4, a decrease of 49.7 average new positive cases reported since Sept 15, 2022  
• 7-day daily average for the percentage of total positive tests: 9.9 percentage points, a decrease of 2.6 percentage points reported since Sept. 15, 2022  
• Hospitalizations: 105 current hospitalizations; critically ill: 8
• Total COVID-19 deaths: 3,121, an increase of 41 since last month including 35 as a result of ongoing Vital Statistics reviews of deaths occurring between June and September.*Case and testing data are based on reporting of lab-confirmed COVID-19 tests only. The number of COVID-19 cases in the community is higher than what is reported because of the use of at-home test kits.  

COVID-19 Vaccinations:  

• Total number of doses administered in Delaware: 1,973,133
• Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 75.7%  
• Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 79.8%  
• Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 81.3%  
• Percent of Delawareans who are fully vaccinated (CDC data): 71.6%  

All qualifying Delawareans should get vaccinated. For a location near you, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.  

COVID-19 Case Vaccination Status Report:  

The following reports capture a weekly breakdown of non-boosted cases, deaths, and hospitalizations for the time frame of Sep 26 – Oct 2, 2022.  
  

Non-boosted: Case – Hospital – Death

Weekly Overview (09/26/22 – 10/02/22)
Non-boosted Cases
Total Non-boosted Cases	819
Total Cases	1269
Percent of Non-boosted Cases	64%
Non-boosted Hospitalized Cases
Total Non-boosted Hospitalized Cases	95
Total Hospitalized Cases	140
Percent of Non-boosted Cases	68%
Non-boosted Deaths
Total Non-boosted Deaths	1
Total COVID-19 Deaths	1
Percent of Non-boosted Deaths	100%

 

Note: Case and Hospitalization Count: based on RTS (Report to State Date) Death: based on DoD (Date of Death)  

  

Long-term Care Statistics:  

As of Thursday, October 13, 2022, there have been a total of 4,705 positive COVID-19 cases involving long-term care residents, and 989 residents of Delaware long-term care facilities have died from complications related to COVID-19. 

 

Resources:  

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:  

 

• Monday – Friday: 8:00 a.m. to 9:00 p.m.  
• Saturday: 9:00 a.m. to 5:00 p.m.  

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.  

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.  

 

### 

 

The Delaware Division of Public Health (DPH), a division of the Delaware Department of Health and Social Services, is a nationally accredited public health agency recognized by the Public Health Accreditation Board for its outstanding dedication to driving change through innovation. DPH is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.  

  

A person who is deaf, hard-of-hearing, deaf-blind or speech-disabled can call the DPH phone number above by using TTY services. Dial 7-1-1 or 800-232-5460 to type your conversation to a relay operator, who reads your conversation to a hearing person at DPH. The relay operator types the hearing person’s spoken words back to the TTY user. To learn more about TTY availability in Delaware, visit http://delawarerelay.com. 

DOVER, DE (Oct. 11, 2022) – The Delaware Division of Public Health (DPH) is announcing two new laboratory-confirmed cases of influenza, one each in New Castle and Sussex counties for the 2022-2023 flu season. The cases involve an unvaccinated 43-year-old Sussex County woman, and an unvaccinated child under 5 years – old in New Castle County, both with influenza strain A. The new cases now confirm influenza in each county in Delaware and bring the total case count to seven.

 

The flu vaccine is recommended for Delawareans 6 months of age and older. Since it takes approximately two weeks after vaccination for antibodies that protect against influenza virus infection to develop in the body, it is important to get vaccinated as early as possible to give your body time to build immunity. Getting the flu vaccine now will also provide protection during the entire flu season. The vaccine can help prevent the flu and can safeguard against serious effects such as hospitalization or death if a person who does receive the vaccine catches the flu. It can also be administered during the same visit as the COVID-19 vaccine, at least one inch apart in the same arm or in a different arm.

 

Flu vaccines are offered through physician’s offices, many pharmacies (including those within grocery stores) and Federally Qualified Health Centers (FQHCs). Flu vaccines are also offered at Public Health clinics for uninsured and underinsured individuals. While DPH no longer holds mass community flu clinics, flu vaccines will be offered at community-based locations where the DPH mobile units also provide additional health services. For locations, visit the flu finder at flu.delaware.gov. The flu is easy to transmit, and you can get it even from seemingly healthy, but unvaccinated, children and adults. Children, older adults and those who have chronic underlying medical conditions are most at risk for complications from the flu and are strongly encouraged to get vaccinated now.

 

In addition to getting an annual flu shot, Delawareans can prevent the spread of the flu the same way they can prevent COVID-19 and other respiratory illnesses:

 

• Wash hands frequently with soap and water or use alcohol-based hand sanitizers
• Cover coughs and sneezes with a tissue
• Maintain 6 feet of space between others, especially those who reside outside of your own home
• Avoid touching your eyes, nose or mouth

The flu and COVID-19 have many similar symptoms, including fever or feeling feverish/chills, cough, shortness of breath or difficulty breathing, fatigue (tiredness), sore throat, runny or stuffy nose, muscle pain or body aches and headaches. Other signs and symptoms of COVID-19 that are different from flu include a change in or loss of taste or smell. If you are sick, the best thing to do is call your health care provider to see if you should get tested for COVID-19 or come in for a visit.

 

Those sick with the flu should stay home from work, school and other gatherings and not return until they have been free of fever – with a temperature of less than 100 degrees F (37.8 degrees C), without the use of fever-reducing medications – for at least 24 hours. People with flu symptoms should avoid close contact with well people in the household; you can give someone the flu 24 hours before you show symptoms and five to seven days after you get sick. Stay well-hydrated by drinking plenty of water and other clear liquids. Over-the-counter medicines can provide symptom relief, but if you suspect you have influenza, call your doctor as they may decide to provide antiviral medications to help hasten recovery and prevent serious complications. This is particularly important for those who feel very sick, are pregnant or have chronic medical conditions.

 

For more information about the flu and where to get vaccinated, visit flu.delaware.gov or call 1-800-282-8672.

 

# # #

 

The Delaware Division of Public Health (DPH), a division of the Delaware Department of Health and Social Services, is a nationally accredited public health agency recognized by the Public Health Accreditation Board for its outstanding dedication to driving change through innovation. DPH is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations. 

 

A person who is deaf, hard-of-hearing, deaf-blind or speech-disabled can call the DPH phone number above by using TTY services. Dial 7-1-1 or 800-232-5460 to type your conversation to a relay operator, who reads your conversation to a hearing person at DPH. The relay operator types the hearing person’s spoken words back to the TTY user. To learn more about TTY availability in Delaware, visit http://delawarerelay.com.

WILMINGTON, Del. – Governor Carney on Thursday formally extended the Public Health Emergency order another 30 days to allow the State of Delaware and medical providers to continue COVID-19 vaccination and testing programs.

Under Delaware law, Public Health Emergency declarations must be renewed every 30 days.

Visit Governor Carney’s website to view the Public Health Emergency extension.

 

###

DOVER, DE (Sept. 1, 2022) ­– The Delaware Division of Public Health (DPH) is announcing several Monkypox virus (MPX) updates including the launch of a Public Health Alert web portal providing access to an updated monkeypox web page. The website, which can be found at de.gov/PublicHealthAlerts, was created by the Department of State’s Government Information Center and is a central landing page from which to access individual web pages for COVID-19, MPX and flu. It is intended to highlight public health issues of elevated concern at the time. 

The updated MPX page, which can still be found at de.gov/monkeypox, provides information on the disease in a more user-friendly format. (COVID-19 information can also continue to be found at de.gov/coronavirus, and flu information at flu.delaware.gov).  The updated MPX site includes a separate section for medical providers seeking information and highlights the most current data related to cases. Delaware now has 25 total MPX cases in the state, which remains low compared to neighboring states which have hundreds. DPH will no longer issue press releases solely for case updates, as the data will be more frequently updated on the webpage. Delaware is taking action to continue to ensure the most at-risk persons are vaccinated against the virus.

Starting Sept. 5, DPH will expand access to the MPX vaccine to those who are immunocompromised.  Conditions may include, but are not necessarily limited to: those with cancer, solid organ or stem cell transplants, those taking immunosuppressive therapy, and individuals with autoimmune disease.

Additionally, DPH is pleased to announce that starting today, Newark Urgent Care began administering MPX vaccine to eligible individuals.  Vaccination is available by appointment only; visit NewarkUrgentCare.org to view eligibility requirements and schedule an appointment.  Vaccine clinics will be held on Thursdays and there is no cost for the vaccine.

Eligible persons also can be vaccinated at the following locations:

• Beebe Healthcare: Individuals can schedule an appointment at beebehealthcare.org/online-scheduling. Walk-ins will not be accepted.
• DPH clinics: Individuals should call the MPX hotline at 866-408-1899 for a screening evaluation. Walk-ins at DPH clinics will not be accepted. Monkeypox vaccinations at DPH clinics will continue to prioritize individuals at highest risk after a DPH evaluation: persons known or presumed to be exposed to someone with MPX in the last 14 days, and certain individuals who have sex with men and who have had multiple sex partners within the past 14 days. As a result, appointments may need to be scheduled a few days out.

Vaccines are available to those confirmed to have been exposed, or who are at higher risk of being exposed to the virus, as well as the immunocompromised, and those engaging in high-risk activities, including sexual practices, that increase exposure to MPX, such as: 

• Gay, bisexual, and other men who have sex with men and have had multiple, or any, anonymous sexual partners in a social network experiencing monkeypox activity, this includes meeting partners through an online website, digital application (“app”), or social event (e.g., a bar or party)
• Transgender women or nonbinary persons assigned male at birth who have sex with men
• Sex workers (of any sexual orientation/gender)
• Staff (of any sexual orientation/gender) at establishments where sexual activity occurs (e.g., bathhouses, saunas, sex clubs)
• Eligibility may be determined by the vaccinating provider and may include (but are not necessarily limited to): those with cancer, solid organ or stem cell transplants, those taking immunosuppressive therapy, and individuals with autoimmune disease.

Individuals should be aware that the vaccine, a two-dose series given 28 days apart, is not considered effective until two weeks after the second dose. Those at higher risk should continue to use preventive measures and reduce engaging in any high-risk behaviors until that time. 

Signs and Symptoms

The symptoms of MPX are similar to but milder than the symptoms of smallpox. Symptoms usually start within three weeks of exposure to the virus. Most people who contract MPX will develop a rash, and some will develop flu-like symptoms beforehand. The flu-like symptoms may include fever, headache, muscle aches and backache, sore throat, cough, swollen lymph nodes, chills, or exhaustion. If someone has flu-like symptoms, they usually will develop a rash one to four days later.

If you suspect you are experiencing any symptoms associated with MPX you should immediately: 

• Contact your health care provider and discuss your symptoms and concerns.
• Self-isolate until all lesions have resolved, the scabs have fallen off, and a fresh layer of intact skin has formed.
• Avoid being intimate with others.
• Make a list of your close and intimate contacts in the last 21 days.

Currently, while there is no specific treatment for MPX, antivirals can be prescribed, though they are not always needed. To learn more information about monkeypox, please visit de.gov/monkeypox. DPH began posting MPX case and vaccine data on the website last week.

DPH launched a hotline for individuals with questions or concerns about MPX. The hotline number is 866-408-1899 and is operational Monday – Friday from 8:30 a.m. to 4:30 p.m. (It will be closed this Monday because of the Labor Day holiday.) Questions may also be emailed to DPHCall@delaware.gov. Both the hotline number and email address share staff with the COVID-19 Call Center. To learn more about MPX prevention programs and resources, visit de.gov/monkeypox.

DOVER, DE (Aug 23, 2022) ­– The Delaware Division of Public Health (DPH) is announcing six additional cases of monkeypox (MPX), bringing the state’s total to 17. Of the six new cases, three individuals are from Sussex County and three are from New Castle County. All cases are considered probable pending confirmatory testing by the Centers for Disease Control and Prevention (CDC).

The New Castle County cases are all males, ages 26, 38 and 57 years old. The Sussex County cases include males who are ages 33, 48 and 58 years old. None of the cases are related to one another. All patients have reported recent high-risk intimate contact prior to onset. The 33-year-old also reported recent travel.

Currently, while there is no specific treatment for MPX, antivirals can be prescribed, though they are not always needed. 

Vaccines are available to those confirmed to have been exposed, or who are at higher risk of being exposed to the virus. Last week, medical providers who offer HIV PrEP began administering vaccine to patients. This week, vaccine access was further expanded to include those engaging in high-risk activities, including sexual practices, that increase exposure to MPX, such as:

• Gay, bisexual, and other men who have sex with men and have had multiple (more than one) or any anonymous sexual partners in a social network experiencing monkeypox activity, this includes meeting partners through an online website, digital application (“app”), or social event (e.g., a bar or party)
• Transgender women or nonbinary persons assigned male at birth who have sex with men
• Sex workers (of any sexual orientation/gender)
• Staff (of any sexual orientation/gender) at establishments where sexual activity occurs (e.g., bathhouses, saunas, sex clubs)

Eligible persons can be vaccinated at the following locations:

• Beebe Healthcare, as of Friday, Aug. 26. Individuals can schedule an appointment at beebehealthcare.org/online-scheduling. Walk-ins will not be accepted.
• DPH clinics: Individuals should call the MPX hotline at 866-408-1899 for a screening evaluation. Walk-ins at DPH clinics will not be accepted. Monkeypox vaccinations at DPH clinics will continue to prioritize individuals at highest risk after a DPH evaluation: persons known or presumed to be exposed to someone with MPX in the last 14 days, and certain individuals who have sex with men and who have had multiple sex partners within the past 14 days. As a result, appointments may need to be scheduled a few days out.
• DPH and CAMP Rehoboth are hosting an event on Aug. 23 at CAMP’s Rehoboth Beach location. The pre-registration for this event is currently full. Walk-ins will not be accepted. DPH is also partnering with AIDS Delaware and the Delaware HIV Consortium to hold a vaccine clinic on Aug. 25 at the Community Services Building in Wilmington. This event is also full. Walk-ins will not be accepted. 

Individuals should be aware that the vaccine, a two-dose series given 28 days apart, is not considered effective until two weeks after the second dose. Those at higher risk should continue to use preventive measures and reduce engaging in any high-risk behaviors until that time.

Signs and Symptoms

The symptoms of MPX are similar to but milder than the symptoms of smallpox. Symptoms usually start within three weeks of exposure to the virus. Most people who contract MPX will develop a rash, and some will develop flu-like symptoms beforehand. The flu-like symptoms may include fever, headache, muscle aches and backache, sore throat, cough, swollen lymph nodes, chills, or exhaustion. If someone has flu-like symptoms, they usually will develop a rash one to four days later.

If you suspect you are experiencing any symptoms associated with MPX you should immediately:

• Contact your health care provider and discuss your symptoms and concerns.
• Self-isolate until all lesions have resolved, the scabs have fallen off, and a fresh layer of intact skin has formed.
• Avoid being intimate with others.
• Make a list of your close and intimate contacts in the last 21 days.

To learn more information about monkeypox, please visit de.gov/monkeypox. DPH began posting MPX case and vaccine data on the website last week.

DPH launched a hotline for individuals with questions or concerns about MPX. The hotline number is 866-408-1899 and is operational Monday – Friday from 8:30 a.m. to 4:30 p.m. Questions may also be emailed to DPHCall@delaware.gov. Both the hotline number and email address share staff with the COVID-19 Call Center. To learn more about MPX prevention programs and resources, visit de.gov/monkeypox.

# # #

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com. 

The Delaware Department of Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.